|
KIAA0907 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.169950E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.137440E-01 |
| Normal-vs-Stage2 |
2.203800E-01 |
| Normal-vs-Stage3 |
1.143220E-01 |
| Normal-vs-Stage4 |
1.695220E-01 |
| Stage1-vs-Stage2 |
5.812200E-01 |
| Stage1-vs-Stage3 |
5.710400E-01 |
| Stage1-vs-Stage4 |
3.812800E-01 |
| Stage2-vs-Stage3 |
8.128000E-01 |
| Stage2-vs-Stage4 |
7.163800E-01 |
| Stage3-vs-Stage4 |
4.618400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.297520E-02 |
| Normal-vs-AfricanAmerican |
6.626300E-02 |
| Normal-vs-Asian |
2.680000E-01 |
| Caucasian-vs-AfricanAmerican |
9.472400E-01 |
| Caucasian-vs-Asian |
9.642400E-01 |
| AfricanAmerican-vs-Asian |
9.866000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.237900E-03 |
| Normal-vs-Female |
9.988500E-02 |
| Male-vs-Female |
4.312800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.207800E-02 |
| Normal-vs-Extreme_Weight |
7.479900E-02 |
| Normal-vs-Obese |
3.043700E-02 |
| Normal-vs-Extreme_Obese |
2.419000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.306400E-01 |
| Normal_Weight-vs-Obese |
8.541400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.394800E-01 |
| Extreme_Weight-vs-Obese |
5.086800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.744600E-01 |
| Obese-vs-Extreme_Obese |
7.367600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.537800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.136400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.750000E-02 |
| Normal-vs-Age(81-100Yrs) |
4.365400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.781600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.377400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.295940E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.120610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.899540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.377700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.842500E-03 |
| Normal-VS-Type2 PRCC |
6.222200E-01 |
| Normal-VS-KIRP CIMP |
3.087800E-01 |
| Normal-VS-Unclassified PRCC |
4.335900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.559300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.380200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.838800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.930600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.141350E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.372800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.624400E-01 |
| Normal-vs-N1 |
2.825600E-02 |
| Normal-vs-N2 |
9.850200E-01 |
| N0-vs-N1 |
9.323700E-02 |
| N0-vs-N2 |
6.214400E-01 |
| N1-vs-N2 |
3.284200E-01 |
|
|
